Learn more

CARDIOLYNX AG

Overview
  • Total Patents
    40
  • GoodIP Patent Rank
    185,505
  • Filing trend
    ⇩ 100.0%
About

CARDIOLYNX AG has a total of 40 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PFLEGER R CHEM FAB, WUHAN UNITED PHARMACEUTICAL CO LTD and SYNAPTEC DEV LLC.

Patent filings per year

Chart showing CARDIOLYNX AGs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Scherhag Armin 31
#2 Sartor Dirk 30
#3 Vankan Pierre 13
#4 Stuckler Hubert 6
#5 Armin Scherhag 5
#6 Dirk Sartor 5
#7 Stückler Hubert 4
#8 Stueckler Hubert 2
#9 Pierre Vankan 2
#10 Stckler Hubert 1

Latest patents

Publication Filing date Title
WO2016135262A1 No donors for the treatment of impaired tissue perfusion
SG11201501014YA Extended release compositions of an aminoalkyl nitrate
TW201204355A Nitrate derivatives of pioglitazone
CN103080095A Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
EP2377855A1 A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases
BRPI0923300A2 "cilostazol nitrate derivatives for the treatment of vascular and metabolic diseases"